AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lexaria Bioscience Corp. Director's Dealing 2021

Jan 15, 2021

34983_dirs_2021-01-14_6ff53acb-2c48-434f-9b52-62f20fc291c6.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2021-01-14

Reporting Person: REESE ALBERT L JR (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	917	Direct